Literature DB >> 21444753

An ezrin-rich, rigid uropod-like structure directs movement of amoeboid blebbing cells.

Anna Lorentzen1, Jeffrey Bamber, Amine Sadok, Ilan Elson-Schwab, Christopher J Marshall.   

Abstract

Melanoma cells can switch between an elongated mesenchymal-type and a rounded amoeboid-type migration mode. The rounded 'amoeboid' form of cell movement is driven by actomyosin contractility resulting in membrane blebbing. Unlike elongated A375 melanoma cells, rounded A375 cells do not display any obvious morphological front-back polarisation, although polarisation is thought to be a prerequisite for cell movement. We show that blebbing A375 cells are polarised, with ezrin (a linker between the plasma membrane and actin cytoskeleton), F-actin, myosin light chain, plasma membrane, phosphatidylinositol (4,5)-bisphosphate and β1-integrin accumulating at the cell rear in a uropod-like structure. This structure does not have the typical protruding shape of classical leukocyte uropods, but, as for those structures, it is regulated by protein kinase C. We show that the ezrin-rich uropod-like structure (ERULS) is an inherent feature of polarised A375 cells and not a consequence of cell migration, and is necessary for cell invasion. Furthermore, we demonstrate that membrane blebbing is reduced at this site, leading to a model in which the rigid ezrin-containing structure determines the direction of a moving cell through localised inhibition of membrane blebbing.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21444753     DOI: 10.1242/jcs.074849

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  63 in total

1.  Ras and Rho GTPases on the move: The RasGRF connection.

Authors:  Piero Crespo; Fernando Calvo; Victoria Sanz-Moreno
Journal:  Bioarchitecture       Date:  2011-07-01

Review 2.  Small Rho GTPases in the control of cell shape and mobility.

Authors:  Arun Murali; Krishnaraj Rajalingam
Journal:  Cell Mol Life Sci       Date:  2013-11-26       Impact factor: 9.261

Review 3.  Phosphoinositides: multipurpose cellular lipids with emerging roles in cell death.

Authors:  Thanh Kha Phan; Scott A Williams; Guneet K Bindra; Fung T Lay; Ivan K H Poon; Mark D Hulett
Journal:  Cell Death Differ       Date:  2019-02-11       Impact factor: 15.828

4.  Physical Plasma Membrane Perturbation Using Subcellular Optogenetics Drives Integrin-Activated Cell Migration.

Authors:  Xenia Meshik; Patrick R O'Neill; N Gautam
Journal:  ACS Synth Biol       Date:  2019-02-22       Impact factor: 5.110

Review 5.  At the leading edge of three-dimensional cell migration.

Authors:  Ryan J Petrie; Kenneth M Yamada
Journal:  J Cell Sci       Date:  2013-02-01       Impact factor: 5.285

Review 6.  Leukocyte migration in the interstitial space of non-lymphoid organs.

Authors:  Wolfgang Weninger; Maté Biro; Rohit Jain
Journal:  Nat Rev Immunol       Date:  2014-03-07       Impact factor: 53.106

7.  Delineating the role of membrane blebs in a hybrid mode of cancer cell invasion in three-dimensional environments.

Authors:  Asja Guzman; Rachel C Avard; Alexander J Devanny; Oh Sang Kweon; Laura J Kaufman
Journal:  J Cell Sci       Date:  2020-04-28       Impact factor: 5.285

8.  Eukaryotic Cell Dynamics from Crawlers to Swimmers.

Authors:  H G Othmer
Journal:  Wiley Interdiscip Rev Comput Mol Sci       Date:  2018-07-19

9.  Effect of hydrogel stiffness on morphology and gene expression pattern of CD44high oral squamous cell carcinoma cells.

Authors:  Hideo Shigeishi; Sho Yokoyama; Hiroshi Murodumi; Miyuki Sakuma; Hiroki Kato; Koichiro Higashikawa; Masaaki Takechi; Kouji Ohta; Masaru Sugiyama
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

10.  Constitutively active ezrin increases membrane tension, slows migration, and impedes endothelial transmigration of lymphocytes in vivo in mice.

Authors:  Yin Liu; Natalya V Belkina; Chung Park; Raj Nambiar; Scott M Loughhead; Genaro Patino-Lopez; Khadija Ben-Aissa; Jian-Jiang Hao; Michael J Kruhlak; Hai Qi; Ulrich H von Andrian; John H Kehrl; Matthew J Tyska; Stephen Shaw
Journal:  Blood       Date:  2011-11-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.